Results 1 to 3 of 3

Thread: Donald Ingber

  1. #1

  2. #2


    Science On Tap: Biologically Inspired Engineering with Donald E. Ingber, MD, PhD

    Published on Oct 12, 2017

    During this live studio recording of Science On Tap, Donald Ingber, MD, PhD will explain to host Graham Chedd why the name of the institute he heads at Harvard, the Wyss Institute for Biologically Inspired Engineering, nicely sums up its goal. Dr. Ingber’s stellar career has focused on turning nature’s solutions to engineering problems into practical technology – such as living cells integrated into microelectronic circuits, or human Organs-on-Chips. He also enjoys collaborating with artists and designers, and is known for his creative use of analogies in explaining his science.

  3. #3


    Roundtable #6 - Human Model Systems w/ Don Ingber @ Wyss Institute & Hans Clevers @ Roche | BIOS

    Jun 26, 2023

    Guests: Don Ingber - Founding Director @ Wyss Institute / Professor @ Harvard & Hans Clevers - Head of Pharma Research & Development (pRED) @ Roche

    Don Ingber is the Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, Judah Folkman Professor of Vascular Biology at Harvard Medical School and Vascular Biology Program at Boston Children’s Hospital, and Professor of Hansjörg Wyss Professor of Bioinspired Engineering, Harvard School of Engineering and Applied Sciences. He received his B.A., M.A., M.Phil., M.D. & Ph.D. from Yale University.

    Ingber is a pioneer in the field of biologically inspired engineering, and at the Wyss Institute, he currently leads scientific and engineering teams that cross a broad range of disciplines to develop breakthrough bio-inspired technologies to advance healthcare and to improve sustainability. His work has led to major advances in mechanobiology, cell structure, tumor angiogenesis, tissue engineering, systems biology, nanobiotechnology and translational medicine. Through his work, Ingber also has helped to break down boundaries between science, art and design.Ingber has authored more than 500 publications and 170 patents, founded 7 companies, and has presented 550 plenary presentations and invited lectures world-wide.

    Ingber has made great strides in translating his innovations into commercial products and many are now either in clinical trials or currently being sold. Examples of technologies Ingber has developed include therapeutics for cancer and pandemic viruses; micropatterned culture substrate research tools; a dialysis-like sepsis therapeutic device that clears blood of pathogens and inflammatory toxins along with a companion diagnostic; an anticoagulant surface coating for medical devices that replaces the need for dangerous blood-thinning drugs; a shear stress-activated nanotherapeutic that targets clot-busting drugs and vasodilators to sites of vascular occlusion; low cost nasopharyngeal swabs and highly sensitive multiplexed electrochemical sensors for COVID-19 diagnostics; and Human Organ Chips lined by living human cells that are being used to replace animal testing for drug development and personalized medicine. Ingber’s Organ Chip technology was named one of the Top 10 Emerging Technologies by the World Economic Forum and Design of the Year by the London Design Museum. It was also acquired by the Museum of Modern Art (MoMA) in New York City for its permanent design collection.

Социальные закладки

Социальные закладки

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •